DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jerrold Boxerman
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital
Phoenix, Arizona, United States
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- Boca Raton Regional Hospital
Boca Raton, Florida, United States
- Baptist Md Anderson Cancer Center
Jacksonville, Florida, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Moffitt Cancer Center - Mckinley Campus
Tampa, Florida, United States
- Moffitt Cancer Center-International Plaza
Tampa, Florida, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Northside Hospital
Atlanta, Georgia, United States
- Northside Hospital-Forsyth
Cumming, Georgia, United States
- Iu Health Methodist Hospital
Indianapolis, Indiana, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- Maryland Proton Treatment Center
Baltimore, Maryland, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Minnesota Oncology Hematology Pa-Maplewood
Maplewood, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Regions Hospital
Saint Paul, Minnesota, United States
- United Hospital
Saint Paul, Minnesota, United States
- Minnesota Oncology Hematology Pa-Woodbury
Woodbury, Minnesota, United States
- Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
- University of Missouri - Ellis Fischel
Columbia, Missouri, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Memorial Sloan Kettering Commack
Commack, New York, United States
- Memorial Sloan Kettering Westchester
East White Plains, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jul 2017
- Primary completion
- 31 Dec 2025
- Completion
- 7 May 2027
- Last update posted
- 15 Sept 2026
- Registered enrollment
- 146
- Registry id
- NCT03115333
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.